Hepatopulmonary syndrome (HPS) is a serious vascular complication of liver disease that
occurs in 5–32% of patients with cirrhosis. The presence of HPS markedly increases …

Hepatopulmonary syndrome (HPS) is characterized as a triad: liver disease, intrapulmonary
vascular dilatation and arterial hypoxemia. HPS is reported to be present in 4% to 32% of …

Liver cirrhosis is associated with multiple vascular syndromes affecting almost all body
systems. Many of these syndromes are directly related to impaired liver function and …

Hepatopulmonary syndrome (HPS) in stable patients with cirrhosis can easily be
overlooked. We report on the presenting symptoms, disease progression, and outcomes …

Background The lack of large hepatopulmonary syndrome cohorts undergoing liver
transplantation (LT) has resulted in limited information about post-LT outcomes and …

Objective To prospectively investigate the prevalence of hepatopulmonary syndrome (HPS),
the importance of pulse oximetry in diagnosing HPS, and the longitudinal course after liver …

Al‐Hussaini A, Taylor RM, Samyn M, Bansal S, Heaton N, Rela M, Mieli‐Vergani G, Dhawan
A. Long‐term outcome and management of hepatopulmonary syndrome in children. Pediatr …

Background Hepatopulmonary syndrome (HPS) is defined as an arterial oxygenation defect
induced by intrapulmonary vascular dilatation (IPVD) associated with hepatic disease. The …

Background Hepatopulmonary syndrome (HPS) is defined as a triad characterized by
arterial deoxygenation, intrapulmonary vascular dilatations (IPVDs), and liver disorder. The …

Complications of cirrhotic portal hypertension (PHTN) in children are broad and include
clinical manifestations ranging from variceal hemorrhage, hepatic encephalopathy (HE) …